Generalized Pustular Psoriasis (GPP) drugs in development, 2024

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP) by five companies/universities/institutes. The top development phase for Generalized Pustular Psoriasis (GPP) is preclinical, with two drugs in that stage.

Charles River works on rare disease gene therapy; Emergent gets $75M for anthrax vaccine; EuroAPI hires new COO

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. Charles River and the Australian

December 1, 2023

Do organic foods really offer better health benefits?

Researchers compare the health impacts of consuming organic foods to conventional alternatives.

September 16, 2024

Harris seeks to tie expanded Medicare drug price negotiation to home care policy

WASHINGTON — Vice President Harris is proposing to use cuts to the pharmaceutical industry’s profits in Medicare to fund a home care benefit for people

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.